Corporate GovernanceAug 7, 2026, 05:03 PM
Coya Therapeutics Appoints Mark Pavao to Audit Committee
AI Summary
Coya Therapeutics, Inc. announced the appointment of Mark H. Pavao to its Audit Committee, effective immediately. This update amends a previous filing regarding his initial appointment to the Board of Directors on April 1, 2026. The Audit Committee now comprises Dr. Dov Goldstein (Chair), Dr. Ann Lee, Dieter Weinand, and Mark H. Pavao.
Key Highlights
- Mark H. Pavao appointed to Coya Therapeutics' Audit Committee.
- Appointment to the Audit Committee is effective immediately as of August 6, 2026.
- The appointment was made upon recommendation from the Nominating and Corporate Governance Committee.
- Current Audit Committee members include Dr. Dov Goldstein (Chair), Dr. Ann Lee, Dieter Weinand, and Mark H. Pavao.
- This amendment clarifies Mr. Pavao's committee assignments following his Board appointment on April 1, 2026.
Price Impact
More from COYA